KemPharm Inc. (KMPH): BUY NOW before release of APADAZ

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Tuesday, 07/16/2019 7:52:02 PM

Tuesday, July 16, 2019 7:52:02 PM

BUY NOW before release of APADAZ - PLUS two news drugs for ADHD. With a market cap of only 43 million, seems very cheap and worth a shot here.

Keep Last Read

Next 10 Prev Next

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2024 11:49:38 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/10/2024 08:23:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2024 11:46:20 AM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/09/2024 04:15:27 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/03/2024 08:17:44 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2024 08:15:21 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/01/2024 09:27:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 08:14:13 PM

InvestorsHub NewsWire

Only $200 per official company press release!